Literature DB >> 21821727

Increased hyaluronan fragmentation during pulmonary ischemia.

Lindsey Eldridge1, Aigul Moldobaeva, Elizabeth M Wagner.   

Abstract

Hyaluronan (HA), a glycosaminoglycan critical to the lung extracellular matrix, has been shown to dissociate into low-molecular-weight (LMW) HA fragments following exposure to injurious stimuli. In the present study we questioned whether lung HA changed during ischemia and whether changes had an effect on subsequent angiogenesis. After left pulmonary artery ligation (LPAL) in mice, we analyzed left lung homogenates immediately after the onset of ischemia (0 h) and intermittently for 14 days. The relative expression of HA synthase (HAS)1, HAS2, and HAS3 was determined by real-time RT-PCR, total HA in the lung was measured by an ELISA-like assay, gel electrophoresis was performed to determine changes in HA size distribution, and the activity of hyaluronidases was determined by zymography. A 50% increase in total HA was measured 16 h after the onset of ischemia and remained elevated for up to 7 days. Furthermore, a fourfold increase in LMW HA fragments (495-30 kDa) was observed by 4 h after LPAL. Both HAS1 and HAS2 showed increased expression 4-16 h after LPAL, yet no changes were seen in hyaluronidase activity. These results suggest that both HA fragmentation and activation of HA synthesis contribute to increased HA levels during lung ischemia. Delivery of LMW HA fragments in an in vitro tube formation assay or directly to the ischemic mouse lung in vivo both resulted in increased angiogenesis. We conclude that ischemic injury results in matrix fragmentation, which leads to stimulation of neovascularization.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21821727      PMCID: PMC3213986          DOI: 10.1152/ajplung.00079.2011

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  23 in total

1.  Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis.

Authors:  R C Savani; G Cao; P M Pooler; A Zaman; Z Zhou; H M DeLisser
Journal:  J Biol Chem       Date:  2001-07-11       Impact factor: 5.157

2.  High MW hyaluronan inhibits smoke inhalation-induced lung injury and improves survival.

Authors:  Pei-ming Huang; Olga Syrkina; Lunyin Yu; Rejmon Dedaj; Hang Zhao; Aviva Shiedlin; Yung-yang Liu; Hari Garg; Deborah A Quinn; Charles A Hales
Journal:  Respirology       Date:  2010-10       Impact factor: 6.424

3.  Angiogenesis induced by degradation products of hyaluronic acid.

Authors:  D C West; I N Hampson; F Arnold; S Kumar
Journal:  Science       Date:  1985-06-14       Impact factor: 47.728

4.  Differential activity of pro-angiogenic CXC chemokines.

Authors:  Aigul Moldobaeva; Amy Baek; Lindsey Eldridge; Elizabeth M Wagner
Journal:  Microvasc Res       Date:  2010-02-06       Impact factor: 3.514

5.  A comparison of the sensitivity, specificity, and molecular weight accuracy of three different commercially available Hyaluronan ELISA-like assays.

Authors:  Sarah Haserodt; Metin Aytekin; Raed A Dweik
Journal:  Glycobiology       Date:  2010-09-23       Impact factor: 4.313

6.  Reactive oxygen species and hyaluronidase 2 regulate airway epithelial hyaluronan fragmentation.

Authors:  Maria E Monzon; Nevis Fregien; Nathalie Schmid; Nieves S Falcon; Michael Campos; S Marina Casalino-Matsuda; Rosanna Malbran Forteza
Journal:  J Biol Chem       Date:  2010-06-16       Impact factor: 5.157

7.  Role of ROS in ischemia-induced lung angiogenesis.

Authors:  Julie Nijmeh; Aigul Moldobaeva; Elizabeth M Wagner
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-08-06       Impact factor: 5.464

8.  The role of CXCR2 in systemic neovascularization of the mouse lung.

Authors:  Jesús Sánchez; Aigul Moldobaeva; Jessica McClintock; John Jenkins; Elizabeth Wagner
Journal:  J Appl Physiol (1985)       Date:  2007-06-07

9.  The enzymatic degradation of hyaluronan is associated with disease progression in experimental pulmonary hypertension.

Authors:  Mark L Ormiston; Graham R D Slaughter; Yupu Deng; Duncan J Stewart; David W Courtman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-11-13       Impact factor: 5.464

10.  Anti-oxidant inhibition of hyaluronan fragment-induced inflammatory gene expression.

Authors:  Michael Eberlein; Kara A Scheibner; Katharine E Black; Samuel L Collins; Yee Chan-Li; Jonathan D Powell; Maureen R Horton
Journal:  J Inflamm (Lond)       Date:  2008-11-05       Impact factor: 4.981

View more
  21 in total

1.  Hyaluronan mediates airway hyperresponsiveness in oxidative lung injury.

Authors:  Ahmed Lazrak; Judy Creighton; Zhihong Yu; Svetlana Komarova; Stephen F Doran; Saurabh Aggarwal; Charles W Emala; Vandy P Stober; Carol S Trempus; Stavros Garantziotis; Sadis Matalon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-03-06       Impact factor: 5.464

2.  Design and characterization of microporous hyaluronic acid hydrogels for in vitro gene transfer to mMSCs.

Authors:  Talar Tokatlian; Cynthia Cam; Shayne N Siegman; Yuguo Lei; Tatiana Segura
Journal:  Acta Biomater       Date:  2012-07-20       Impact factor: 8.947

3.  Upregulation of airway smooth muscle calcium-sensing receptor by low-molecular-weight hyaluronan.

Authors:  Ahmed Lazrak; Zhihong Yu; Stephen Doran; Ming-Yuan Jian; Judy Creighton; Mandy Laube; Stavros Garantziotis; Y S Prakash; Sadis Matalon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-01-08       Impact factor: 5.464

4.  Hyaluronan synthase control of synthesis rate and hyaluronan product size are independent functions differentially affected by mutations in a conserved tandem B-X7-B motif.

Authors:  Bruce A Baggenstoss; Edward N Harris; Jennifer L Washburn; Andria P Medina; Long Nguyen; Paul H Weigel
Journal:  Glycobiology       Date:  2016-08-24       Impact factor: 4.313

5.  Hyaluronan stimulates ex vivo B lymphocyte chemotaxis and cytokine production in a murine model of fungal allergic asthma.

Authors:  Sumit Ghosh; Scott A Hoselton; Steve B Wanjara; Jennifer Carlson; James B McCarthy; Glenn P Dorsam; Jane M Schuh
Journal:  Immunobiology       Date:  2015-02-07       Impact factor: 3.144

6.  Porous hyaluronic acid hydrogels for localized nonviral DNA delivery in a diabetic wound healing model.

Authors:  Talar Tokatlian; Cynthia Cam; Tatiana Segura
Journal:  Adv Healthc Mater       Date:  2015-02-18       Impact factor: 9.933

7.  Lack of hyaluronidases exacerbates renal post-ischemic injury, inflammation, and fibrosis.

Authors:  Vanessa Colombaro; Inès Jadot; Anne-Emilie Declèves; Virginie Voisin; Laetitia Giordano; Isabelle Habsch; Jérémy Malaisse; Bruno Flamion; Nathalie Caron
Journal:  Kidney Int       Date:  2015-02-25       Impact factor: 10.612

8.  Non-viral DNA delivery from porous hyaluronic acid hydrogels in mice.

Authors:  Talar Tokatlian; Cynthia Cam; Tatiana Segura
Journal:  Biomaterials       Date:  2014-01       Impact factor: 12.479

Review 9.  The role of hyaluronan in the pathobiology and treatment of respiratory disease.

Authors:  Stavros Garantziotis; Martin Brezina; Paolo Castelnuovo; Lorenzo Drago
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-01-08       Impact factor: 5.464

10.  Acute Lung Injury Regulation by Hyaluronan.

Authors:  Patrick A Singleton; Frances E Lennon
Journal:  J Allergy Ther       Date:  2011-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.